- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00786877
Cookstove Replacement for Prevention of ALRI and Low Birthweight in Nepal
January 15, 2015 updated by: James M. Tielsch, Johns Hopkins Bloomberg School of Public Health
At our field site in southern Nepal, acute respiratory illness (ARI) has been a leading cause of mortality among young children.
Besides immunization there is little evidence for effective primary preventive approaches for ARI on a population basis.
Low birth weight is highly prevalent in this population as well affecting approximately 30% of live born infants.
Low birth weight is a key determinant of neonatal mortality and has also been resistant to cost-effective interventions in resource poor settings.
Given the lack of appropriate interventions for poor, rural areas in developing countries and the strong observational association between open burning of biomass fuel sources and ARI in young children and low birth weight, we have designed a community-based randomized trial to determine if reductions in household indoor smoke exposure can reduce the incidence and duration of acute lower respiratory infections in children <36 months of age and low birthweight among newborn infants.
Household indoor smoke reduction will be accomplished by replacing the current cook stove in the household with a locally appropriate, inexpensive model that is more efficient and vented to the exterior.
In addition, we will assess the impact on respiratory function and symptoms among adults in the household.
The project has 2 phases.
Phase 1 is a cluster-randomized, community-based, step-wedge trial of cookstove replacement in a rural population of southern Nepal.
Households will be randomized to receive replacement of their cook stove with an appropriately designed, efficient stove that is vented to the exterior at different time periods during the course of the study.
An initial period of surveillance for ARI and low birth weight will establish a baseline rate for all clusters.
This will be followed by the randomized, serial replacements of cook stoves over a 12 month period.
Surveillance will continue throughout this period and for an additional 6 -18 months depending on when the stove was replaced.
Phase 2 is a individually randomized trial in a subset of households that will receive either the improved biomass stove from phase 1 or a LPG stove and gas.
Follow-up for phase 2 will be for 12 months with the same outcomes as phase 1. Measurement of indoor air particulate concentration will be conducted in all households before and after stove replacement.
The analysis for both phases will focus on estimating the impact on incidence of ARI in children and low birth weight among live births as a result of stove replacement.
Approximately 4200 children 1-35 months of age will be required to observe a minimum 10% reduction in risk of ARI with 90% power in phase 1.
Given the expected number of live births to occur in these clusters, we can detect a 50 gram difference in birthweight with over 90% power and a type I error of 5%.
Phase 2 will have lower power (total of 1800 households).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
See brief summary above
Study Type
Interventional
Enrollment (Actual)
4678
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kathmandu, Nepal
- Nepal Nutrition Intervention Project Sarlahi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 3 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Phase 1
Inclusion Criteria:
- All households with traditional open burning cookstoves in the study area.
Exclusion Criteria:
- Houses with walls of thatch or bamboo
Phase 2
Inclusion criteria:
- households in the phase 1 study area that either participated in phase 1 or are newly eligible household since phase 1 began. Eligible households are those with either a resident married pregnant woman or at least one child less than 24 months of age.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Improved biomass cookstove with exterior ventilation
In phase 1, installation of an improved cookstove with ventilation to exterior is the active arm. In phase 2, this improved biomass cookstove is the control arm. |
Improved cookstove design installed in house that is higher efficiency and is vented to the exterior.
Other Names:
|
No Intervention: Traditional cookstove
In phase 1, the control arm is the traditional standard open burning cookstove in house.
|
|
Experimental: Phase 2 invervention arm (LPG stove)
In phase 2 of this project, households are individually randomized to either continuation of the improved biomass stove from phase 1, or a new LPG stove and gas for 12 months.
|
LPG two burner stove with a 12 month supply of LP gas.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Incidence of acute lower respiratory illness.
Time Frame: <36 months of age
|
<36 months of age
|
Incidence of Low Birthweight
Time Frame: All live births
|
All live births
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Incidence of pre-term birth
Time Frame: all live births
|
all live births
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2009
Primary Completion (Actual)
May 1, 2014
Study Completion (Actual)
May 1, 2014
Study Registration Dates
First Submitted
November 5, 2008
First Submitted That Met QC Criteria
November 5, 2008
First Posted (Estimate)
November 6, 2008
Study Record Updates
Last Update Posted (Estimate)
January 16, 2015
Last Update Submitted That Met QC Criteria
January 15, 2015
Last Verified
January 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00000332
- R01ES015558 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Lower Respiratory Illness
-
University of Colorado, DenverBiofireCompletedAcute Respiratory Infection | Lower Respiratory Tract Illness | Respiratory Pathogens | Upper Respiratory Tract IllnessUnited States
-
PfizerActive, not recruitingLower Respiratory Tract IllnessUnited States, Netherlands, Canada, Japan, Finland, Argentina, South Africa
-
National Institute of Allergy and Infectious Diseases...Mexican Emerging Infectious Diseases Clinical Research NetworkCompletedSevere Acute Respiratory IllnessMexico
-
University of Southern DenmarkOdense University Hospital; Region of Southern Denmark; Odense Patient Data Explorative... and other collaboratorsCompletedAcute Illness | Acute Respiratory DiseaseDenmark
-
OM Pharma SAParexelRecruitingRecurrent Wheezing | Wheezing Lower Respiratory IllnessUnited States
-
University of FloridaNational Institutes of Health (NIH); Universite d'Etat d'HaitiCompletedAcute Respiratory Infection | Acute Febrile Illness | Acute DiarrheaHaiti
-
Centers for Disease Control and PreventionKenya Medical Research Institute; MCM Vaccines B.V.; Kenya Ministry of HealthUnknownInfluenza | Severe Acute Respiratory Illness | Influenza Like IllnessKenya
-
Altesa Biosciences, Inc.Virtus Respiratory ResearchRecruitingRCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory InfectionInfections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases | Lung Diseases | Pulmonary Disease, Chronic Obstructive | Enterovirus Infections | Copd | Pulmonary Disease | Respiratory Disease | Respiratory Complication | Upper Respiratory Tract Infections | Respiratory Viral Infection | ... and other conditionsUnited Kingdom
-
Mayo ClinicEnrolling by invitation
-
University of RochesterNational Institute of Nursing Research (NINR)Completed